Evidence map›Paper›PMID 36821596›Full record

ArticlePLoS pathogens2023

Architecture and matrix assembly determinants of Bordetella pertussis biofilms on primary human airway epithelium.

Audra R Fullen, Jessica L Gutierrez-Ferman, Rachael E Rayner, Sun Hee Kim, Phylip Chen, Purnima Dubey, Daniel J Wozniak, Mark E Peeples, Estelle Cormet-Boyaka, Rajendar Deora

Abstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Opposing effects of acellular and whole cell pertussis vaccines onbioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Audra R FullenThe Department of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
Jessica L Gutierrez-FermanThe Department of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
Rachael E RaynerDepartment of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, United States of America.
Sun Hee KimDepartment of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, United States of America.
Phylip ChenCenter for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
Purnima DubeyThe Department of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
Daniel J WozniakThe Department of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
Mark E PeeplesCenter for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
Estelle Cormet-BoyakaDepartment of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, United States of America.
Rajendar DeoraThe Department of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.ORCID 0000-0002-6093-8354

Funding

The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
Identification of novel immunogenic proteins from Bordetella pertussisR01AI153829 · NIAID · OHIO STATE UNIVERSITY · PI DEORA, RAJENDAR K, DUBEY, PURNIMA · 2021 to 2025
$3.8M
Interdisciplinary Program in Microbe-Host BiologyT32AI165391 · NIAID · OHIO STATE UNIVERSITY · PI RAJENDAR K DEORA, Daniel J Wozniak · 2022 to 2026
$1.5M
Bioengineered Multi-Cell Type Organoids For Airways Disease ModelingR01HL143076 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MURPHY, SEAN VINCENT · 2019 to 2021
$1.2M
Bordetella cell surface modification and pathogenesisR21AI156732 · NIAID · OHIO STATE UNIVERSITY · PI DEORA, RAJENDAR K · 2021 to 2022
$454k
NCATS NIH HHS UL1 TR002733NHLBI NIH HHS R01 HL143076NIAID NIH HHS R01 AI153829NIAID NIH HHS R21 AI156732NIAID NIH HHS T32 AI165391
6 · The paper itself

Abstract

Traditionally, whooping cough or pertussis caused by the obligate human pathogen Bordetella pertussis (Bp) is described as an acute disease with severe symptoms. However, many individuals who contract pertussis are either asymptomatic or show very mild symptoms and yet can serve as carriers and sources of bacterial transmission. Biofilms are an important survival mechanism for bacteria in human infections and disease. However, bacterial determinants that drive biofilm formation in humans are ill-defined. In the current study, we show that Bp infection of well-differentiated primary human bronchial epithelial cells leads to formation of bacterial aggregates, clusters, and highly structured biofilms which are colocalized with cilia. These findings mimic observations from pathological analyses of tissues from pertussis patients. Distinct arrangements (mono-, bi-, and tri-partite) of the polysaccharide Bps, extracellular DNA, and bacterial cells were visualized, suggesting complex heterogeneity in bacteria-matrix interactions. Analyses of mutant biofilms revealed positive roles in matrix production, cell cluster formation, and biofilm maturity for three critical Bp virulence factors: Bps, filamentous hemagglutinin, and adenylate cyclase toxin. Adherence assays identified Bps as a new Bp adhesin for primary human airway cells. Taken together, our results demonstrate the multi-factorial nature of the biofilm extracellular matrix and biofilm development process under conditions mimicking the human respiratory tract and highlight the importance of model systems resembling the natural host environment to investigate pathogenesis and potential therapeutic strategies.

Indexed as

Bordetella pertussisWhooping CoughBiofilmsEpitheliumHumansRespiratory System

Identifiers

PMID36821596
PMCPMC9990917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.